Yersinia pestis is the causative agent of plague, a devastating disease that in three pandemics resulted in more human deaths than any other infectious agent (45, 69) .
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caf1A gene for F1 pilus (capsular) assembly as an escape mechanism of Y. pestis for naturally occurring immunity in infected animals.
MATERIALS AND METHODS
Bacterial strains and plasmids. Yersinia pestis CO92, a fully virulent wild-type plague isolate (16) , was grown on heart infusion agar (HIA) supplemented with 0.2% galactose and 0.0075% Congo red (58) and incubated at 26ºC for 48 hours. The mean lethal dose (MLD) for bubonic plague following subcutaneous injection of BALB/c mice is 1 colony forming unit (cfu) for Y. pestis CO92. Y. pestis KIM D27 (pFra + , pCD1 + , pPCP1 + , ∆pgm)(6) was used as parental strain for allelic replacement. The KIM D27 ∆F1 strain has been described previously (48) . The KIM D27 caf1A::IS1541 (CAC2) mutation was generated by amplifying the caf1A gene from pFra plasmid of strain CO92
caf1A::IS1541 (CAC1) with the following primers: caf1AFOSphI (5'-TAGCATGCATGAGGTATTCAAAGCTGTTCC -3') and caf1ADOSacI (5'-TAGAGCTCTCAGTTATTTAAGATGCAGG-3'). The amplified product was ligated into the SphI/SacI sites of pCVD442 (Amp R ). The recombinant plasmid was electroporated into KIM D27 and single crossover events were selected by plating on HIA supplemented with 50 µg/ml ampicillin. Resolution of replication defective plasmid co-integrates was achieved by plating on HIA supplemented with 10% sucrose as counter-selection for sacB (5) . Ampicillin-sensitive and sucrose-resistant colonies were examined by PCR and DNA sequencing to confirm mutant genotypes. We screened 250 colonies with this technology and identified one mutant, which was designated CAC2. 
Protein analysis. Proteins were separated by electrophoresis on 15% sodium dodecyl sulfate (SDS)-polyacrylamide gels (PAGE) and stained with Coomassie Brilliant
Blue. For immunoblots, proteins were transferred to polyvinylidene difluoride membranes (Millipore) and probed with anti-sera as previously described (11) .
Digitonin Fractionation Assay. HeLa cells were grown in DMEM (GIBCO™)
supplemented with 10% fetal bovine serum (FBS) and 2 mM glutamine at 37°C in 5% CO 2 . Overnight Y. pestis cultures in heart infusion broth (HIB) were grown at 26°C. The following day, cultures were diluted 1:20 into fresh HIB and 2.5 mM CaCl 2 with appropriate antibiotic and were grown at 26°C for 2 hours. One hour prior to infection, 90% confluent HeLa cells were washed 2 times with phosphate buffered saline (PBS) and 10 ml of DMEM (GIBCO™) media. HeLa cells were infected with indicated Yersinia strains at an MOI of 10. Three hours following infection, the tissue culture medium (M) was decanted and centrifuged at 15,000 rpm for 15 minutes. Proteins in 10 ml of supernatant (S) were precipitated with trichloroacetic acid and the rest of the supernatant discarded. Pellets (P) were suspended in 10 ml of 1% SDS in PBS and 10 ml of the pellet Immunofluorescence microscopy. Y. pestis KIM D27, ∆F1, and CAC2 were grown in 4 ml HIB and 2.5mM CaCl 2 overnight at 37°C and bacteria in the culture were sedimented by centrifugation (5 min at 6,000 ×g). Bacteria in the sediment were washed with 1 ml of phosphate-buffered saline (PBS, 10 mM sodium phosphate), fixed with 2.5% paraformaldehyde and 0.006% glutaraldehyde in 30 mM PBS (pH 7.4) for 20 min at room temperature and washed 3 times with 1 ml PBS. Bacterial suspensions (30 µl)
were applied to L-polylysine coated coverslips for 5 minutes, washed 3 times with 60 µl PBS to remove non-adherent cells and allowed to dry. Plague bacteria were rehydrated in 60 µl of PBS for 5 minutes, blocked with 3% bovine serum albumin (BSA) in PBS for increments) plus one transmitted light detector with 12-bit output and 6.5× and 13.5× digital zoom. Captured images were analyzed with Image J TM software.
RESULTS

Yersinia pestis break-through challenge of immunized mice. To examine Y.
pestis escape from F1-mediated immune responses, we purified recombinant F1 (rF1) and immunized cohorts of BALB/c mice with two intra-muscular injections of 50 µg rF1 adsorbed to Alhydrogel® separated by a twenty-one day interval. Vaccine success was measured as antibody titers in serum samples (Fig. 1A) . On average, immunized animals harbored rF1-specific IgG with titers of 1:75,000 (±31,000), whereas mock immunized animals displayed titers <1:800 (P<0.01). Mice were challenged by subcutaneous injection with increasing doses of the highly virulent wild-type isolate Y. pestis CO92.
Immunized animals challenged with 1×10 5 MLD were fully protected from lethal bubonic plague, whereas animals injected with adjuvant alone (PBS/ Alhydrogel®) succumbed to disease (Fig. 1B) . Animals challenged with 1×10 6 MLD exhibited 20% mortality. Lethal disease was increased when the challenge dose was elevated to 1×10 7 and 1×10 8 MLD (Fig. 1B) . Lymph node, blood, lung and spleen tissue homogenates for two animals from each of the high challenge cohorts were spread on Congo red agar plates and isolated colonies analyzed by PCR (Table 1) . Bacterial isolates from rF1-immunized animals exhibited positive PCR-tests for caf1 and lcrV. F1-immunized animals challenged with 1×10 7 MLD harbored plague bacteria in their lymph nodes, and in one animal these had spread to the spleen. One of the animals challenged with 1×10
12
MLD displayed a disseminated infection ( Table 1) . As a test for escape variants, one colony each from isolated strains was re-inoculated into rF1-immunized animals. Mice infected with the isolate from animal #2 succumbed to this challenge (Table 1) .
Y. pestis break-through variants harbor an IS1541 insertion in caf1A. Y.
pestis CAC1 (#2) failed to secrete F1, however small amounts of pilus antigen were found in the bacterial sediment (Fig. 1E ). PCR and DNA sequencing revealed the absence of mutational lesions in caf1, however the caf1A gene harbored an IS1541
insertion in reverse orientation at nucleotide 1263 of its open reading frame, thereby disrupting the outer membrane usher and Y. pestis pilus assembly (51) (Fig. 1CD ). To test whether the caf1A::IS1541 lesion is solely responsible for the defect in pilus assembly, the mutation was introduced into the non-pigmented variant Y. pestis KIM D27
(6) to generate strain CAC2 (Fig. 1E) . Fractionation of bacterial cultures confirmed that the caf1A::IS1541 mutation indeed abolished F1 secretion. Viewed by microscopy and fluorescent antibody, Y. pestis KIM D27 displayed its F1 capsule, whereas isogenic caf1 deletion and caf1A::IS1541 insertion variants did not (Fig. 1F) . which revealed an MLD of 1×10 3 cfu, similar to that of wild-type strain Y. pestis CO92 (Fig. 2B) . Pneumonic plague infected animals (n=5) were also killed 24, 48 and 36 hours post challenge to monitor bacterial dissemination from lung tissue to the spleen (Fig. 2C) .
Y. pestis CO92 and CAC1 displayed similar kinetics of replication in lung tissue on day 1 (CO92 7,700 ± 5,310 vs. CAC1 9,400 ± 9,009 cfu, P≤0. (Fig. 2C) . Histopathology of infected lung tissues on the first day of infection revealed very few changes in lung architecture (Fig. 2D) . On the second and third day, alveolar spaces were obstructed with large aggregates of immune cell infiltrates and bacteria (Fig. 2D) . Lung parenchyma harbored multi-focal areas of necrosis that obliterated the normal lung architecture, indicating that the caf1A::IS1541insertion does not affect virulence during pneumonic plague (Fig. 2D) . These results are similar to the pathology results of pneumonic plague in African green monkeys challenged with (Fig. 5C ).
Deletion of the structural gene for F1 pili (caf1) from Y. pestis KIM D27 enabled isogenic ∆F1 mutants to escape the type III inhibitory attributes of F1-specific MAbs (Fig. 5D ).
The caf1A::IS1541 mutation caused the same effect and restored Y. pestis type III injection even in the presence of F1-specific antibodies (Fig. 5E ). As controls, neither 
DISCUSSION
Type III injection of effector Yops is an essential virulence mechanism of Y.
pestis (46) and LcrV plays an essential role by gating this transport pathway at the tip of its needle structures (41) . Immunization with purified LcrV antigen generates specific antibodies that block type III injection (47) and confer plague protective immunity (7).
However, these antibodies are not sufficiently developed in plague infected animals or in animals immunized with live-attenuated vaccine strains (10, 48) . Instead, humoral immune responses are directed largely at capsular antigen (F1 pili) (10, 48) . F1-specific antibodies enable phagocytic clearance (9) and, as suggested here, likely impact Yersinia type III injection (17) . These results aid in the appreciation of plague protective immunity, as research into the discovery of additional plague protective antigens has thus far failed to identify envelope components that achieve comparable levels of vaccine protection as that described for LcrV and F1 (12, 55 c Time-of-death following injection of the challenge dose.
d Polymerase chain reaction test with primers specific for pCD1-encoded lcrV and pFra-encoded caf1 scored as positive (+) or negative (-).
e Numbers or rF1-immunized animals (average anti-F1 IgG ELISA titer 1:75,000) that survived challenge with 1,000 cfu of plague bacteria isolated during necropsy of animals #1, #2, and #4.
f NA, not applicable on October 2, 2017 by guest
